Live News EQUITY M impact Jun 22, 2026, 11:01 AM UTC

AGMB: HC Wainwright Initiates Buy

HC Wainwright & Co. initiates coverage on AgomAb Therapeutics with a buy rating and a price target of $35

SQUAWKNEWS Updated Jun 22, 2026, 11:05 AM UTC

HC Wainwright & Co.

Initiates Coverage On AgomAb Therapeutics with Buy Rating, Announces Price Target of $35